Therapeutic approaches to target alpha-synuclein pathology
Year: 2017
Type: article
Source: Experimental Neurology
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Foundation for the National Institutes of Health, Michael J. Fox Foundation for Parkinson's Research, Parkinson's Disease Foundation, Teva Pharmaceutical Industries, AbbVie, Cure Parkinson’s Trust, Axial Biotherapeutics, Lundbeckfonden, National Institutes of Health, National Institute on Deafness and Other Communication Disorders, National Institute of Neurological Disorders and Stroke
OpenAlex ID: W2761522803
